FDA Approves Animas’ Vibe Linking Insulin Pump With DexCom CGM
This article was originally published in The Gray Sheet
The insulin pump is the first FDA-approved device featuring Dexcom’s G4 Platinum sensing technology; it allows patients to see glucose data and administer insulin directly from the pump.
You may also be interested in...
The United Kingdom’s National Health Service should adopt Medtronic’s MiniMed Paradigm Veo insulin pump/glucose monitor system over rival systems for patients with type 1 diabetes who experience disabling hypoglycemia, the country's National Institute for Health and Care Excellence recommends.
Product announcements from LivaNova, Smith & Nephew, Medtronic, Boston Scientific and Animas.
Tandem Diabetes Care’s t:slim G4 insulin pump/continuous glucose monitor system is the latest DexCom partnership to yield an FDA approval, and the first integrated diabetes system to feature a touch-screen display.